1. Home
  2. HUDI vs ASBP Comparison

HUDI vs ASBP Comparison

Compare HUDI & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huadi International Group Co. Ltd.

HUDI

Huadi International Group Co. Ltd.

N/A

Current Price

$0.69

Market Cap

11.5M

Sector

Industrials

ML Signal

N/A

Logo Aspire Biopharma Holdings Inc.

ASBP

Aspire Biopharma Holdings Inc.

N/A

Current Price

$8.11

Market Cap

12.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HUDI
ASBP
Founded
1998
2021
Country
China
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
12.4M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
HUDI
ASBP
Price
$0.69
$8.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.4K
★ 32.5K
Earning Date
06-29-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$0.05
52 Week High
$1.67
$9.50

Technical Indicators

Market Signals
Indicator
HUDI
ASBP
Relative Strength Index (RSI) 33.53 49.44
Support Level $0.66 $7.88
Resistance Level $0.98 $9.50
Average True Range (ATR) 0.04 0.55
MACD -0.01 -0.09
Stochastic Oscillator 0.00 31.20

Price Performance

Historical Comparison
HUDI
ASBP

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

About ASBP Aspire Biopharma Holdings Inc.

Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.

Share on Social Networks: